Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
Authors
Keywords
mucosal vaccine, protein antigen, adjuvant, immunostimulant, vaccine delivery system
Journal
Protein & Cell
Volume 6, Issue 7, Pages 480-503
Publisher
Springer Nature
Online
2015-05-05
DOI
10.1007/s13238-015-0164-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes)
- (2016) Anshuman Shukla et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Combatting infectious diseases; nanotechnology as a platform for rational vaccine design
- (2014) Elly van Riet et al. ADVANCED DRUG DELIVERY REVIEWS
- Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery
- (2014) Simi Mathew et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Oral delivery of nanoparticle-based vaccines
- (2014) Nirmal Marasini et al. Expert Review of Vaccines
- Current advancements and potential strategies in the development of MERS-CoV vaccines
- (2014) Naru Zhang et al. Expert Review of Vaccines
- Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens
- (2014) Neil C. Sheppard et al. INTERNATIONAL IMMUNOLOGY
- M-cell targeted polymeric lipid nanoparticles containing a toll-like receptor agonist to boost oral immunity
- (2014) Tongtong Ma et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Biomaterials for Nanoparticle Vaccine Delivery Systems
- (2014) Preety Sahdev et al. PHARMACEUTICAL RESEARCH
- Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
- (2014) Maria Victoria Sanchez et al. PLoS One
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice
- (2014) Fawad Mansoor et al. RESEARCH IN VETERINARY SCIENCE
- HIV Vaccines: A Brief Overview
- (2014) D. Lema et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Algae-based oral recombinant vaccines
- (2014) Elizabeth A. Specht et al. Frontiers in Microbiology
- Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo
- (2013) Kenichi Niikura et al. ACS Nano
- Polymer Nanomicelles for Efficient Mucus Delivery and Antigen-Specific High Mucosal Immunity
- (2013) Young-Woock Noh et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An overview of adjuvant formulations and delivery systems
- (2013) Alexis García et al. APMIS
- Recent Advances in Claudin-Targeting Technology
- (2013) Shotaro Nagase et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan
- (2013) Tao Jiang et al. BIOMATERIALS
- Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
- (2013) Il Gyu Kong et al. INFECTION AND IMMUNITY
- Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: A needle-free vaccination strategy
- (2013) Sara Vicente et al. JOURNAL OF CONTROLLED RELEASE
- A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV
- (2013) T. M. Turner et al. JOURNAL OF VIROLOGY
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- Gold nanoparticle–M2e conjugate coformulated with CpG induces protective immunity against influenza A virus
- (2013) Wenqian Tao et al. Nanomedicine
- Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration
- (2013) Sanyog Jain et al. Nanomedicine-Nanotechnology Biology and Medicine
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- A decade after SARS: strategies for controlling emerging coronaviruses
- (2013) Rachel L. Graham et al. NATURE REVIEWS MICROBIOLOGY
- M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A
- (2013) Lorena Itatí Ibañez et al. PLoS One
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres
- (2013) Joshua J. Reineke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterogeneity of single molecule FRET signals reveals multiple active ribosome subpopulations
- (2013) Yuhong Wang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Local and systemic immune responses in mice to intranasal delivery of peptides representing bovine respiratory syncytial virus epitopes encapsulated in poly (dl-lactide-co-glycolide) microparticles
- (2013) Owen V. Kavanagh et al. RESEARCH IN VETERINARY SCIENCE
- Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
- (2013) Qinjian Zhao et al. TRENDS IN BIOTECHNOLOGY
- Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)
- (2013) Tania Rivera-Hernandez et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Evaluation of the Effectiveness and Safety of Chitosan Derivatives as Adjuvants for Intranasal Vaccines
- (2013) Takashi Kobayashi et al. VIRAL IMMUNOLOGY
- Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3
- (2013) Kyosuke Senchi et al. Frontiers in Microbiology
- Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
- (2013) Yeong-Min Park et al. Immune Network
- Microparticle surface modifications targeting dendritic cells for non-activating applications
- (2012) Jamal S. Lewis et al. BIOMATERIALS
- Protecting against plague: towards a next-generation vaccine
- (2012) E. D. Williamson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mucosal immunity and nasal influenza vaccination
- (2012) Markus A Rose et al. Expert Review of Vaccines
- A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
- (2012) Signe C. Svindland et al. Influenza and Other Respiratory Viruses
- Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice
- (2012) Riyasat Ali et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies
- (2012) Ganesh Barhate et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: A preliminary study as possible vaccine against genital herpes
- (2012) Rita Cortesi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
- (2012) Bert Devriendt et al. JOURNAL OF CONTROLLED RELEASE
- Chitosan-based drug nanocarriers: Where do we stand?
- (2012) Marcos Garcia-Fuentes et al. JOURNAL OF CONTROLLED RELEASE
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
- (2012) Frank Wegmann et al. NATURE BIOTECHNOLOGY
- Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
- (2012) Qing Zhu et al. NATURE MEDICINE
- Structural vaccinology starts to deliver
- (2012) Philip R. Dormitzer et al. NATURE REVIEWS MICROBIOLOGY
- Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
- (2012) Viviana Buffa et al. PLoS One
- Chimeric hepatitis E virus-like particle as a carrier for oral-delivery
- (2012) Pitchanee Jariyapong et al. VACCINE
- Hepatitis E vaccine development
- (2012) Ting Wu et al. Human Vaccines & Immunotherapeutics
- A New Strategy Based on Smrho Protein Loaded Chitosan Nanoparticles as a Candidate Oral Vaccine against Schistosomiasis
- (2012) Carolina R. Oliveira et al. PLoS Neglected Tropical Diseases
- Binding of bacterial secondary messenger molecule c di-GMP is a STING operation
- (2012) Neil Shaw et al. Protein & Cell
- Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
- (2011) Samar Hamdy et al. ADVANCED DRUG DELIVERY REVIEWS
- Preparation and investigation of Ulex europaeus agglutinin I-conjugated liposomes as potential oral vaccine carriers
- (2011) KeXin Li et al. ARCHIVES OF PHARMACAL RESEARCH
- In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A
- (2011) Federica Sarti et al. BIOMATERIALS
- Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes
- (2011) Anshuman Shukla et al. BRITISH JOURNAL OF PHARMACOLOGY
- Application of Ulex europaeus Agglutinin I-Modified Liposomes for Oral Vaccine: Ex Vivo Bioadhesion and in Vivo Immunity
- (2011) KeXin Li et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles
- (2011) Yoshio Fujita et al. Chemistry Central Journal
- Defending the mucosa: adjuvant and carrier formulations for mucosal immunity
- (2011) Louise B Lawson et al. CURRENT OPINION IN IMMUNOLOGY
- Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice
- (2011) Suzanne M. Bal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Improved antigen cross-presentation by polyethyleneimine-based nanoparticles
- (2011) Chen et al. International Journal of Nanomedicine
- Viral protein complexed liposomes for intranasal delivery of hepatitis B surface antigen
- (2011) Shailja Tiwari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity
- (2011) Keisuke Matsuo et al. JOURNAL OF CONTROLLED RELEASE
- Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen
- (2011) J.F.S. Mann et al. JOURNAL OF CONTROLLED RELEASE
- Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization
- (2011) Basant Malik et al. JOURNAL OF DRUG TARGETING
- Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques
- (2011) L. Liu et al. JOURNAL OF VIROLOGY
- Intracellular Targeting of PLGA Nanoparticles Encapsulating Antigenic Peptide to the Endoplasmic Reticulum of Dendritic Cells and Its Effect on Antigen Cross-Presentationin Vitro
- (2011) Hadas Sneh-Edri et al. MOLECULAR PHARMACEUTICS
- A 2020 vision for vaccines against HIV, tuberculosis and malaria
- (2011) Rino Rappuoli et al. NATURE
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases
- (2011) Bret D. Ulery et al. PLoS One
- Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits
- (2011) Herman F. Staats et al. PLoS One
- Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice
- (2011) Shu Meng et al. PLoS One
- Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP
- (2011) Gabriel Kristian Pedersen et al. PLoS One
- Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines
- (2011) Stacey L. Demento et al. TRENDS IN BIOTECHNOLOGY
- Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
- (2011) Thomas Ebensen et al. VACCINE
- Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
- (2011) Lissette S. Velasquez et al. VACCINE
- Targeted delivery of chitosan nanoparticles to Peyer’s patch using M cell-homing peptide selected by phage display technique
- (2010) Mi-Kyong Yoo et al. BIOMATERIALS
- Archaeal lipid mucosal vaccine adjuvant and delivery system
- (2010) Girishchandra B Patel et al. Expert Review of Vaccines
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Bioadhesive delivery systems for mucosal vaccine delivery
- (2010) Barbara C. Baudner et al. JOURNAL OF DRUG TARGETING
- The M Cell-Targeting Ligand Promotes Antigen Delivery and Induces Antigen-Specific Immune Responses in Mucosal Vaccination
- (2010) S.-H. Kim et al. JOURNAL OF IMMUNOLOGY
- Immunoglobulin immobilized liposomal constructs for transmucosal vaccination through nasal route
- (2010) Brajesh Tiwari et al. JOURNAL OF LIPOSOME RESEARCH
- Interleukin-1 Family Cytokines as Mucosal Vaccine Adjuvants for Induction of Protective Immunity against Influenza Virus
- (2010) H. Kayamuro et al. JOURNAL OF VIROLOGY
- Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers
- (2010) Riccardo Muzzarelli Marine Drugs
- Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines
- (2010) Shailja Tiwari et al. Nanomedicine
- Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies
- (2010) Rebecca Klippstein et al. Nanomedicine-Nanotechnology Biology and Medicine
- Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide
- (2010) Yu-Shiun Chen et al. NANOTECHNOLOGY
- Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
- (2010) Tomonori Nochi et al. NATURE MATERIALS
- Corrigendum to “The member of the cyclic di-nucleotide family bis-(3′,5′)-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant” [Vaccine 28 (2010) 2249–2258]
- (2010) Rimma Libanova et al. VACCINE
- Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
- (2010) Zhiwei Sui et al. VACCINE
- The Eurocine® L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination
- (2010) Pernilla Petersson et al. VACCINE
- Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens
- (2009) Edmund J. Gosselin et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant
- (2009) Hiroyuki Kayamuro et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TMC–MCC (N-trimethyl chitosan–mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines
- (2009) Burcu Sayın et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization
- (2009) Mariko Ishii et al. GLYCOCONJUGATE JOURNAL
- The ABC of clinical and experimental adjuvants—A brief overview
- (2009) Richard Brunner et al. IMMUNOLOGY LETTERS
- Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses
- (2009) Par Bahadur Pun et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres
- (2009) N. Brandhonneur et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses
- (2009) Chandan Thomas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PEG–PLA–PEG block copolymeric nanoparticles for oral immunization against hepatitis B
- (2009) Arvind K. Jain et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes
- (2009) Anshuman Shukla et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Preparation andin vivostudy of dry powder microspheres for nasal immunization
- (2009) Mohsen Tafaghodi et al. JOURNAL OF DRUG TARGETING
- Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B
- (2009) R. S. Pandey et al. JOURNAL OF DRUG TARGETING
- Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity
- (2009) L. Wang et al. JOURNAL OF VIROLOGY
- Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa
- (2009) S A Khader et al. Mucosal Immunology
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
- (2009) Xiaoxing Huang et al. PLoS One
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
- (2009) David J. M. Lewis et al. PLoS One
- Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens
- (2009) Amy N. Courtney et al. VACCINE
- Advances in saponin-based adjuvants
- (2009) Hong-Xiang Sun et al. VACCINE
- ISCOMs and ISCOMATRIX™
- (2009) Hong-Xiang Sun et al. VACCINE
- Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection
- (2009) Jamie F.S. Mann et al. VACCINE
- The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ɛ-caprolactone-based nanoparticles
- (2008) H.F. Florindo et al. BIOMATERIALS
- Virus-sized vaccine delivery systems
- (2008) J SCHEERLINCK et al. DRUG DISCOVERY TODAY
- Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles
- (2008) Olga Borges et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres
- (2008) S. Abolghasem Sajadi Tabassi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Safety of Intranasally Administered Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery (AMVAD) Vaccine in Mice
- (2008) Girishchandra B. Patel et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
- (2008) Sameer Sharma et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
- (2008) C. Trumpfheller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
- An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles
- (2008) Luca Santi et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started